Cancer Research and Treatment

Original Articles

Gastrointestinal cancer

First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017: Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sang-Jae Park, Young-Joo Won, Sun-Whe Kim; Cancer Res Treat. 2022;54(1):208-217. Published online May 21, 2021; DOI: https://doi.org/10.4143/crt.2021.421

Purpose
Hospital-based clinical studies have limitations in holistic assessment of cancer treatment and prognosis, as they omit out-of-hospital patients including elderly individuals. This study aimed to investigate trends in initial treatment and corresponding prognosis of patients with exocrine pancreatic cancer (EPC) in Korea.
Materials and Methods
The Korea Central Cancer Registry data of patients with EPC from 2006 to 2017 were retrospectively reviewed. We defined the first course of treatment (FT) as the cancer-directed treatment administered within four months after cancer diagnosis according to Surveillance, Epidemiology, and End Results (SEER) program.
Results
Among 62,209 patients with EPC, localized and regional (LR) SEER stage; patients over 70 years old; and ductal adenocarcinoma excluding cystic or mucinous (DAC) accounted for 40.6%, 50.1%, and 95.9%, respectively. “No active treatment” (NT, 46.5%) was the most frequent, followed by non-surgical FT (28.7%) and surgical FT (22.0%). Among 25,198 patients with LR EPC, surgical FT increased (35.9% to 46.3%) and NT decreased (45.0% to 29.5%) from 2006 to 2017. The rate of surgical FT was inversely related to age (55.1% [< 70 years], 37.3% [70-79 years], 10.9% [≥ 80 years]). Five-year relative survival rates of LR DAC were higher after surgical FT than after NT in localized (46.1% vs. 12.9%) and regional stage (23.6% vs. 4.9%) from 2012 to 2017.
Conclusion
Less than half of overall patients with LR EPC underwent surgical FT, and this proportion decreased significantly in elderly individuals. Clinicians should focus attention on elderly patients with EPC to provide appropriate medical advice.

Citations

Citations to this article as recorded by

Epidemiology of Gastric Cancer in Korea (1999–2022): Incidence, Survival, and 5-Year Conditional Relative Survival
Ki Bum Park, Mee Joo Kang, Johyun Ha, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Kyu-Won Jung, Han Hong Lee
Journal of Gastric Cancer.2026; 26(1): 4. CrossRef
Long-term conditional relative survival trends in extrahepatic bile duct cancer: insights from a population-based retrospective cohort study in a high-incidence Asian Country, 1999–2021
Mee Joo Kang, Johyun Ha, Sang-Jae Park, Hyeong Min Park, Kyu-Won Jung, Sung-Sik Han
International Journal of Surgery.2026; 112(4): 10010. CrossRef
Conditional Relative Survival of Gallbladder Cancer: A Population-Based Study in a High-Incidence Asian Country from 1999 to 2021
Mee Joo Kang, Johyun Ha, Sang-Jae Park, Hyeong Min Park, Kyu-Won Jung, Sung-Sik Han
Annals of Surgical Oncology.2025; 32(9): 6272. CrossRef
Incidence, mortality, and survival of gallbladder, extrahepatic bile duct, and pancreatic cancers in Korea: A population-based study from 1999 to 2022
Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Kyu-Won Jung, Sang-Jae Park
Annals of Hepato-Biliary-Pancreatic Surgery.2025; 29(3): 209. CrossRef
Updates on incidence, mortality and survival of liver cancer using Korea central cancer registry database: 1999–2022
Sung Yeon Hong, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Bong-Wan Kim, Kyu-Won Jung
Annals of Hepato-Biliary-Pancreatic Surgery.2025; 29(4): 381. CrossRef
Conditional Relative Survival of Exocrine Pancreatic Cancer: A Population-Based Study
Mee Joo Kang, Johyun Ha, Hyeong Min Park, Sang-Jae Park, Kyu-Won Jung, Sung-Sik Han
Annals of Surgical Oncology.2024; 31(2): 1178. CrossRef
Potential role of Fibrosis‐4 score in hepatocellular carcinoma screening: The Kangbuk Samsung Health Study
Sujeong Shin, Won Sohn, Yoosoo Chang, Yoosun Cho, Min‐Jung Kwon, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu
Hepatology Research.2024; 54(6): 551. CrossRef
Three-year follow-up study reveals improved survival rate in NSCLC patients underwent guideline-concordant diagnosis and treatment
Huijuan Mu, Xing Yang, Yanxia Li, Bingzheng Zhou, Li Liu, Minmin Zhang, Qihao Wang, Qian Chen, Lingjun Yan, Wei Sun, Guowei Pan
Frontiers in Oncology.2024;[Epub] CrossRef
Epidemiological trends and factors associated with survival in patients with medulloblastoma: A 45-year population-based retrospective study
Dongjie He, Yahui Yang, Peiwen Wu, Siying Zhu, Hao Chang, Chao Zhang, Qiuju Shao, Zongyan Yu
Journal of Clinical Neuroscience.2024; 126: 154. CrossRef
Surgical management for elderly patients with pancreatic cancer
Sun-Whe Kim
Annals of Surgical Treatment and Research.2023; 105(2): 63. CrossRef
Exocrine pancreatic cancer as a second primary malignancy: A population-based study
Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sung Chun Cho, Sang-Jae Park, Sun-Whe Kim, Young-Joo Won
Annals of Hepato-Biliary-Pancreatic Surgery.2023; 27(4): 415. CrossRef
Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study
Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sun-Whe Kim, Woo Jin Lee, Sang Myung Woo, Tae Hyun Kim, Young-Joo Won, Sang-Jae Park
Scientific Reports.2022;[Epub] CrossRef
Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
Journal of Korean Medical Science.2022;[Epub] CrossRef
Epidemiology of Gastric Cancer in Korea: Trends in Incidence and Survival Based on Korea Central Cancer Registry Data (1999–2019)
Sin Hye Park, Mee Joo Kang, E Hwa Yun, Kyu-Won Jung
Journal of Gastric Cancer.2022; 22(3): 160. CrossRef
Incidence, mortality and survival of gallbladder, extrahepatic bile duct, and pancreatic cancer using Korea central cancer registry database: 1999-2019
Mee Joo Kang, E Hwa Yun, Kyu-Won Jung, Sang-Jae Park
Annals of Hepato-Biliary-Pancreatic Surgery.2022; 26(3): 220. CrossRef
Incidence, mortality, and survival of liver cancer using Korea central cancer registry database: 1999-2019
Sung Yeon Hong, Mee Joo Kang, Taegyu Kim, Kyu-Won Jung, Bong-Wan Kim
Annals of Hepato-Biliary-Pancreatic Surgery.2022; 26(3): 211. CrossRef

9,026 View
123 Download
15 Web of Science
16 Crossref

Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009: Sang-Hoon Shin, Kyu-Won Jung, Johyun Ha, Seung Hoon Lee, Young-Joo Won, Heon Yoo; Cancer Res Treat. 2015;47(4):569-574. Published online February 12, 2015; DOI: https://doi.org/10.4143/crt.2014.085

Abstract PDF PubReader ePub

Purpose
Primary central nervous system lymphoma (PCNSL) is an uncommon brain tumor accounting for 2%-5% of all primary brain tumors. Few population-based analyses of survival for patients with PCNSL have been conducted, particularly in Asian countries. Materials and Methods Using the Korea National Cancer Incidence Database, 1,062 cases of PCNSL newly diagnosed from 1999 to 2009 were analyzed. The crude rate, age-standardized rate (ASR), and annual percent change were calculated. To estimate the observed survival, we restricted the data to between 1999 and 2007 and followed the cases until December 2010. The overall survival was estimated using the Kaplan-Meier method, and piecewise Poisson regression model.
Results
The ASR for PCNSL between 1999 and 2009 was 0.17 per 100,000, and the annual percent change from 1999 to 2009 was 8.8% (p < 0.001). The ASR of males was higher than that of females, and the older groups (60s or over) showed the largest increase in incidence rates. For all ages, the five-year survival from PCNSL was 29.9% between 1999 and 2007. Survival from PCNSL is known to show strong association with age at diagnosis. Conclusion These results are similar to those of previous studies. Our findings may be helpful to clinicians and patients in determining long-term prognoses for PCNSL.

Citations

Citations to this article as recorded by

Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland
Emmy Ojala, Hanne Kuitunen, Aino Rönkä, Eetu Pellonperä, Tuomas Selander, Inka Puhakka, Outi Kuittinen
BMC Cancer.2026;[Epub] CrossRef
Real-world challenges in primary central nervous system lymphoma: a case series
Rita Cagigal, André Miranda, Lino Mascarenhas, Amélia Mendes
Neurological Sciences.2026;[Epub] CrossRef
All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis
Taylor FURST, Haydn HOFFMAN, Lawrence S. CHIN
Journal of Neurosurgical Sciences.2024;[Epub] CrossRef
Intrathecal IgM synthesis as a diagnostic marker in patients with suspected CNS lymphoma
Raphael Reinecke, Kolja Jahnke, Martha Foltyn‐Dumitru, Karsten Lachner, Moritz Armbrust, Katharina J. Weber, Pia S. Zeiner, Marcus Czabanka, Uta Brunnberg, Sylvia Hartmann, Joachim P. Steinbach, Michael W. Ronellenfitsch
Journal of Neurochemistry.2024; 168(6): 1157. CrossRef
Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis
Han Shi, Xuefei Sun, Yuchen Wu, Qu Cui, Shengjun Sun, Nan Ji, Yuanbo Liu
Journal of Clinical Neuroscience.2024; 124: 36. CrossRef
Defining MRI-based follow-up protocol for primary central nervous system lymphoma
Inka K. Puhakka, Kaisa L. Sunela, Aino L. Rönkä, Aino M. Rajamäki, Ulla-Mari Arkko, Tuula M. Klaavuniemi, Milla E.L Kuusisto, Pekka A. Jäkälä, Tuomas A. Selander, Hanne K. Kuitunen, Anne-Mari Kantanen, Outi M. Kuittinen
Annals of Hematology.2024;[Epub] CrossRef
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
Ethan A. Burns, Cesar Gentille Sanchez, Sunil Mathur, Carlo Guerrero, Ibrahim N. Muhsen, Humaira Sarfraz, Chih-Chi Andrew Hu, Chih-Hang Anthony Tang, Shilpan S. Shah, Ivo W. Tremont, Bin Teh, Siddhartha Ganguly, Sai Ravi Kiran Pingali
Annals of Hematology.2023; 102(5): 1111. CrossRef
Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma
Yao Hu, Qingyun Zhang, Zhiyuan Wu, Kun Chen, Xiao Xu, Weizhe Ma, Bobin Chen, Limin Jin, Ming Guan
Discover Oncology.2023;[Epub] CrossRef
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
Inka Puhakka, Hanne Kuitunen, Pekka Jäkälä, Eila Sonkajärvi, Taina Turpeenniemi-Hujanen, Aino Rönkä, Tuomas Selander, Miika Korhonen, Outi Kuittinen
BMC Cancer.2022;[Epub] CrossRef
Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
Julette Marie F Batara, Almira Doreen Abigail O Apor, Christianne V Mojica, Mark Willy L Mondia
Neuro-Oncology Advances.2022;[Epub] CrossRef
The International Vitreoretinal B-Cell Lymphoma Registry: a protocol paper
Justine R Smith, Alexandra L Farrall, Janet L Davis, Joke H de Boer, Anthony J Hall, Manabu Mochizuki, H Nida Sen, Hiroshi Takase, Ninette H ten Dam-van Loon, Valérie Touitou, Daniel V Vasconcelos-Santos, David J Wilson, Steven Yeh, Mark H B Radford
BMJ Open.2022; 12(7): e060701. CrossRef
Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study
Alexandra L. Farrall, Justine R. Smith
Cancers.2021; 13(3): 403. CrossRef
Eye involvement in primary central nervous system lymphoma
Alexandra L. Farrall, Justine R. Smith
Survey of Ophthalmology.2020; 65(5): 548. CrossRef
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study
Chava Perry, Sharon Ben Barouch, Neta Goldschmidt, Nadav Sarid, Yair Herishanu, Lev Shvidel, Osnat Bairey, Noa Lavi, Netanel Horowitz, Avraham Avigdor, Eyal Lebel, Orit Sofer, Ron Ram, Irit Avivi
American Journal of Hematology.2019; 94(9): 992. CrossRef
Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989–2015
M van der Meulen, A G Dinmohamed, O Visser, J K Doorduijn, J E C Bromberg
Leukemia.2017; 31(8): 1822. CrossRef
Role of radiation therapy in primary central nervous system lymphoma
Hyeon Kang Koh, Il Han Kim, Tae Min Kim, Do Hoon Lim, Dongryul Oh, Jae Ho Cho, Woo-Chul Kim, Jin Hee Kim, Woong-Ki Chung, Bae-Kwon Jeong, Ki Mun Kang, Semie Hong, Chang-Ok Suh, In Ah Kim
Journal of Neuro-Oncology.2017; 135(3): 629. CrossRef

15,112 View
126 Download
17 Web of Science
16 Crossref

Incidence and Treatment Pattern of Extremity Soft Tissue Sarcoma in Korea, 2009-2011: A Nationwide Study Based on the Health Insurance Review and Assessment Service Database: Seungcheol Kang, Han-Soo Kim, Eun-Seok Choi, Ilkyu Han; Cancer Res Treat. 2015;47(4):575-582. Published online January 2, 2015; DOI: https://doi.org/10.4143/crt.2014.047

Abstract PDF PubReader ePub

Purpose
We conducted a nationwide study to assess the incidence and treatment patterns of extremity soft tissue sarcoma (STS) in South Korea.
Materials and Methods
The nationwide incidence and treatment patterns of extremity STS were assessed using two nationwide databases, the Korea National Cancer Incidence (KNCI) database and the Health Insurance Review and Assessment Service (HIRA) database.
Results
A total of 1,236 patients were newly diagnosed with extremity STS during the 3-year study period, from 2009 to 2011. The annual incidence of extremity STS in the Korean population was approximately 0.9 per 100,000 people with a male bias that increased with age and was especially pronounced amongst individuals aged > 80 years. Approximately 7% of patients did not receive any treatment, and surgical excision was performed for 85% of those who were treated.
Conclusion
This is the first nationwide study of the incidence and treatment patterns of extremity STS in Korea using two national databases (KNCI and HIRA), which include the entire Korean population. The results of this study may be useful for future planning and management of STS, at the national level.

Citations

Citations to this article as recorded by

Spectrum of Soft Tissue Sarcomas - A Retrospective Analysis in a Tertiary Care Centre
R Priya Dharshini, Neelayadakshi B, Sonti Sulochana
Malaysian Journal of Medicine and Health Sciences.2024; 20(s3): 1. CrossRef
Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy
Jung Min Bae, Hyun Jeong Ju, Ro Woo Lee, Sang Ho Oh, Jeong Hyun Shin, Hee Young Kang, Ji Hun Park, Hee Jung Kim, Ki-Heon Jeong, Hee Jung Lee, SangHoon Lee, Dong Hyun Kim, Dong-Youn Lee, You Chan Kim, Gwang Seong Choi, Ki-Ho Kim, Chul Jong Park, Chong Won
JAMA Dermatology.2020; 156(5): 529. CrossRef
Incidence of soft tissue sarcoma in Taiwan: A nationwide population-based study (2007–2013)
Giun-Yi Hung, Jiun-Lin Horng, Paul Chih-Hsueh Chen, Li-Yih Lin, Jinn-Yang Chen, Pei-Hung Chuang, Ta-Chung Chao, Chueh-Chuan Yen
Cancer Epidemiology.2019; 60: 185. CrossRef
Molecular changes in solitary fibrous tumor progression
Hyung Kyu Park, Dan Bi Yu, Minjung Sung, Ensel Oh, Mingi Kim, Ji-Young Song, Mi-Sook Lee, Kyungsoo Jung, Ka-Won Noh, Sungbin An, Kyoung Song, Do-Hyun Nam, Yu Jin Kim, Yoon-La Choi
Journal of Molecular Medicine.2019; 97(10): 1413. CrossRef
Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea
Hyo Song Kim, Chung Mo Nam, Suk-Yong Jang, Sun Kyu Choi, Minkyung Han, Seonmin Kim, Maria Victoria Moneta, Sae Young Lee, Jae Min Cho, Diego Novick, Sun Young Rha
Cancer Research and Treatment.2019; 51(4): 1380. CrossRef
Breast reconstruction statistics in Korea from the Big Data Hub of the Health Insurance Review and Assessment Service
Jae-Won Kim, Jun-Ho Lee, Tae-Gon Kim, Yong-Ha Kim, Kyu Jin Chung
Archives of Plastic Surgery.2018; 45(05): 441. CrossRef
Clinical research using medical big data
Geum Joon Cho
Anesthesia and Pain Medicine.2017; 12(1): 9. CrossRef

14,950 View
133 Download
10 Web of Science
7 Crossref

Annual Report of the Korea Central Cancer Registry Program 2000: Based on Registered Data from 131 Hospitals: Jong Myon Bae, Young Joo Won, Kyu Won Jung, Jae Gahb Park; Cancer Res Treat. 2002;34(2):77-83. Published online April 30, 2002; DOI: https://doi.org/10.4143/crt.2002.34.2.77

Abstract PDF

PURPOSE
The Korea Central Cancer Registry (KCCR) program completed a nationwide hospital-based cancer registry to provide basic statistical data on cancer incidence.
MATERIALS AND METHODS
In 2000, 131 hospitals participated in the KCCR program. All cancer registry data, which were submitted by the participating hospitals during the year, were reviewed and analyzed by the committee members.
RESULTS
Of the 94,474 cases that were registered, 7,735 (8.2%) duplication cases were excluded. Of the remaining 86,739 cases, 2,893 cases (3.3%) of carcinoma in situ (morphology code/2) were excluded, leaving a final total of 83,846 cases for analysis, 48,005 (57.3%) male and 35,841 (42.7%) female. The leading age group was 60-64years (15.1%). The six leading primary cancer sites in the order of their relative frequency were the stomach (20.8%), lung (12.2%), liver (12.2%), colorectum (10.3%), breast (6.5%), and uterine cervix (4.5%). In males, the three leading primary cancer sites were the stomach (24.5%), liver (16.3%), and lung (16.3%). In females, the stomach (15.8%), breast (15.1%), and uterine cervix (10.6%). Among the 1,126 cases of childhood malignancies, leukemia (32.7%) was the most common cancer type.
CONCLUSION
We report our analysis of the KCCR data from 131 nationwide hospitals during 2000.

Citations

Citations to this article as recorded by

Morin Hydrate Sensitizes Hepatoma Cells and Xenograft Tumor towards Cisplatin by Downregulating PARP-1-HMGB1 Mediated Autophagy
Mahendra Pal Singh, Tejinder Pal Khaket, Vivek K. Bajpai, Saleh Alfarraj, Se-Gie Kim, Lei Chen, Yun Suk Huh, Young-Kyu Han, Sun Chul Kang
International Journal of Molecular Sciences.2020; 21(21): 8253. CrossRef
Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
Valiollah Mehrzad, Mahnaz Roayaei, Mohammad Saleh Peikar, Elham Nouranian, Fariborz Mokarian, Mohsen Khani, Somaieh Farzannia
Advanced Biomedical Research.2016;[Epub] CrossRef
Helicobacter pyloriInfection and Intestinal Metaplasia among Healthy Adolescents
Ji Sook Park, Kyuyol Rhie, Ji-Hyun Seo, Eo Young Ryu, Hyun-Jin Kim, Hong-Jun Kim, Jae-Young Lim, Hyang-Ok Woo, Seung-Chul Baik, Woo-Kon Lee, Myung-Je Cho, Kwang-Ho Rhee, Gyung-Hyuck Ko, Hee-Shang Youn
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(4): 243. CrossRef
Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer
In Gyu Hwang, Joung-Soon Jang, Sung Yong Oh, Myung Hwan Rho, Suee Lee, Young Suk Park, Joon Oh Park, Eun Mi Nam, Hyo Rak Lee, Hyun Jung Jun, Kyong-Choun Chi
Cancer Chemotherapy and Pharmacology.2015; 75(4): 757. CrossRef
Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer
Seung Tae Kim, Hye-Lim Jang, Jeeyun Lee, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Min Gew Choi, Jae Moon Bae, Tae Sung Sohn, Jae Hyung Noh, Sung Kim, Kyoung-Mee Kim, Won Ki Kang, Joon Oh Park
Translational Oncology.2015; 8(4): 288. CrossRef
Outcomes of advanced gastric cancer in young adult patients treated with first-line combination chemotherapy
Hyun-Jun Kim, Kyoung Kim
International Journal of Cancer Therapy and Oncology.2015; 3(4): 344. CrossRef
Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows PotentIn VitroAntitumor Activity in Gastric Cancer Cell Lines withFGFR2Amplification
Seung Tae Kim, Hye-Lim Jang, Su Jin Lee, Jeeyun Lee, Yoon-La Choi, Kyoung-Mee Kim, Jeonghee Cho, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Masakazu Yashiro, Won Ki Kang, Joon Oh Park
Molecular Cancer Therapeutics.2014; 13(11): 2527. CrossRef
A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers
Jeeyun Lee, Sung Kim, Phillip Kim, Xinjun Liu, Tani Lee, Kyoung-Mee Kim, In-Gu Do, Joon Oh Park, Se Hoon Park, Jiryeon Jang, Nicholas Hoe, Gulia Harvie, Anne Kuller, Anjali Jain, Gary Meyer, Glen Leesman, Young Suk Park, Min Gew Choi, Tae Sung Sohn, Jae M
PLoS ONE.2013; 8(1): e54644. CrossRef
Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer
G.-W. Lee, J.-Y. Kim, E.-H. Koh, D. Kang, D.S. Choi, K.-Y. Maeng, J.-S. Lee
Genetics and Molecular Research.2012; 11(4): 4034. CrossRef
P21-Activated Kinase 4 Overexpression in Metastatic Gastric Cancer Patients
Hee Kyung Ahn, Jiryeon Jang, Jeeyun Lee, Hoon Park Se, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Kyoung-Mee Kim, Won Ki Kang
Translational Oncology.2011; 4(6): 345. CrossRef
Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
Taekyu Lim, Jeeyun Lee, Duk Joo Lee, Ha Yeon Lee, Boram Han, Kyung Kee Baek, Hee Kyung Ahn, Su Jin Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Kyoung-Mee Kim, Won Ki Kang
Cancer Chemotherapy and Pharmacology.2011; 68(1): 255. CrossRef
Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models
Kyung Kee Baek, Jung-Hoon Kim, Ji Eun Uhm, Se Hoon Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Won Ki Kang, Ho Yeong Lim
Oncology.2011; 80(3-4): 167. CrossRef
A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer
JUNG HAN KIM, HYEONG SU KIM, DAE RO CHOI, GEUNDOO JANG, JUNG HYE KWON, HO YOUNG KIM, JOO YOUNG JUNG, HYO JUNG KIM, HUN HO SONG, YUN HO SHIN, SO YOUNG JUNG, BYUNG CHUN KIM, DAE YOUNG ZANG
Oncology Letters.2011; 2(6): 1253. CrossRef
Effect of Benzothiazole based conjugates in causing apoptosis by Regulating p53, PTEN and MAP Kinase proteins affecting miR-195a and miR-101-1
SNCVL Pushpavalli, M Janaki Ramaiah, Ch Srinivas, Debasmita Mukhopadhya, JL Aditya, Ravindra M Kumbhare, Utpal Bhadra, Manika Pal Bhadra
Cancer Cell International.2011;[Epub] CrossRef
Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer
Su-Hee Cho, Se-Il Go, Gyeong-Won Lee, Jung Hun Kang, Hoon-Gu Kim, Seok Hyun Kim, Yu Ji Cho, Yi Yeong Jeong, Ho-Cheol Kim, Jong Duk Lee, Young Sil Hwang
Lung Cancer.2010; 69(1): 94. CrossRef
Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case–control study
Sue K. Park, Lisa Y. Cho, Jae Jeong Yang, Boyoung Park, Soung Hoon Chang, Kun-Sei Lee, Hyeongsu Kim, Keun-Young Yoo, Choon-Taek Lee
Lung Cancer.2010; 68(1): 20. CrossRef
Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer
Jung Hye Kwon, Jung Han Kim, Jung-Ae Lee, Hyun Chun Shin, Hyo Jung Kim, Hun Ho Song, Joo Young Jung, Ho Young Kim, Dae Ro Choi, Hyeong Su Kim, Young-iee Park, Dae Young Zang
Cancer Chemotherapy and Pharmacology.2010; 66(5): 889. CrossRef
Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer
Hyo Jin Lee, Do Yeun Cho, Ji Chan Park, Sang Byung Bae, Kyu Taek Lee, In Sung Cho, Chang Soon Han, Suk Young Park, Hwan Jung Yun, Samyong Kim
Cancer Chemotherapy and Pharmacology.2009; 63(3): 427. CrossRef
Phase II study of S-1 and irinotecan combination chemotherapy as a first-line therapy for patients with advanced gastric cancer. Korean Cancer Study Group Protocol ST05-02
Hye J KANG, Sang H CHO, Suk J OH, Sung H YANG, Moon H LEE, Eun-Kee SONG, Hyun C CHUNG, Im I NA, Baek-Yeol RYOO
Asia-Pacific Journal of Clinical Oncology.2009; 5(1): 46. CrossRef
A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma
Ji Eun Uhm, Joon Oh Park, Jeeyun Lee, Young Suk Park, Se Hoon Park, Byung Chul Yoo, Seung Woon Paik, Kwang Cheol Koh, Won Ki Kang, Ho Yeong Lim
Cancer Chemotherapy and Pharmacology.2009; 63(5): 929. CrossRef
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
Seong Yoon Yi, Young Suk Park, Hyo Song Kim, Hyun Jung Jun, Kyoung Ha Kim, Myung Hee Chang, Min Jae Park, Ji Eun Uhm, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Jong Kyun Lee, Kyu Taek Lee, Ho Yeong Lim, Won Ki Kang
Cancer Chemotherapy and Pharmacology.2009; 63(6): 1141. CrossRef
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
Kyoung Ha Kim, Young Suk Park, Myung Hee Chang, Hyo Song Kim, Hyun Jung Jun, Jieun Uhm, Seong Yoon Yi, Do Hyoung Lim, Sang Hoon Ji, Min Jae Park, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang
Cancer Chemotherapy and Pharmacology.2009; 64(2): 347. CrossRef
A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
Sang Hoon Ji, Do Hyoung Lim, Seong Yoon Yi, Hyo Song Kim, Hyun Jung Jun, Kyoung Ha Kim, Myung Hee Chang, Min Jae Park, Ji Eun Uhm, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
BMC Cancer.2009;[Epub] CrossRef
Impact of Standardized Rhus verniciflua Stokes Extract as Complementary Therapy on Metastatic Colorectal Cancer: A Korean Single-Center Experience
Sang-hun Lee, Won-cheol Choi, Seong-woo Yoon
Integrative Cancer Therapies.2009; 8(2): 148. CrossRef
Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma
Dongho Choi, Hyo Won Lee, Kyung Yul Hur, Jae Joon Kim, Gyeong-Sin Park, Si-Hyong Jang, Young Soo Song, Ki-Seok Jang, Seung Sam Paik
World Journal of Gastroenterology.2009; 15(18): 2258. CrossRef
Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy
Se Hoon Park, Moon Sook Cho, Young Saing Kim, Junshik Hong, Eunmi Nam, Jinny Park, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon Kee Lee
Quality of Life Research.2008; 17(2): 207. CrossRef
Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study
Se Hoon Park, Young Saing Kim, Junshik Hong, Jinny Park, Eunmi Nam, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon Kee Lee, Min Chung
Anti-Cancer Drugs.2008; 19(3): 303. CrossRef
A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
H J Kang, H M Chang, T W Kim, M-H Ryu, H-J Sohn, J H Yook, S T Oh, B S Kim, J-S Lee, Y-K Kang
British Journal of Cancer.2008; 98(2): 316. CrossRef
Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study
Yeul Hong Kim, Hyun Cheol Chung, Won Ki Kang, Sook Ryun Park, Chul Soo Kim, Tae-Yue Kim, Sang Won Shin, Byung-Joo Park, Soo Jin Cha, Yung-Jue Bang
Cancer Chemotherapy and Pharmacology.2008; 62(2): 263. CrossRef
Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
Se Hoon Park, Junshik Hong, Young Saing Kim, Yujin Kim, Sun Young Kyung, Chang Hyeok An, Sang Pyo Lee, Jeong Woong Park, Sung Hwan Jeong, Jinny Park, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Lung Cancer.2008; 62(1): 72. CrossRef
Comparison of the 13C-urea breath test and the endoscopic phenol red mucosal pH test in the quantification of Helicobacter pylori infection loading
Young-Seok Cho, Hiun-Suk Chae, Se Na Jang, Jin-Soo Kim, Hye Suk Son, Hyung-Keun Kim, Byung-Wook Kim, Sok-Won Han, Kyu-Yong Choi, Hae Kyung Lee, Eun Deok Chang
The Korean Journal of Internal Medicine.2008; 23(3): 134. CrossRef
Salvage Chemotherapy With Biweekly Irinotecan, Plus 5-Fluorouracil and Leucovorin in Patients With Advanced Gastric Cancer Previously Treated With Fluoropyrimidine, Platinum, and Taxane
Sun Jin Sym, Min-Hee Ryu, Jae-Lyun Lee, Heung Moon Chang, Tae Won Kim, Sung Sook Lee, Jung Shin Lee, Yoon-Koo Kang
American Journal of Clinical Oncology.2008; 31(2): 151. CrossRef
Adenosine Kinase Gene Expression in Human Colorectal Cancer
S. Giglioni, R. Leoncini, E. Aceto, A. Chessa, S. Civitelli, A. Bernini, G. Tanzini, F. Carraro, A. Pucci, D. Vannoni
Nucleosides, Nucleotides and Nucleic Acids.2008; 27(6-7): 750. CrossRef
Impact of E2F-1 Expression on Clinical Outcome of Gastric Adenocarcinoma Patients with Adjuvant Chemoradiation Therapy
Jeeyun Lee, Cheol Keun Park, Joon Oh Park, Taekyu Lim, Young Suk Park, Ho Yeong Lim, Inkyoung Lee, Tae Sung Sohn, Jae Hyung Noh, Jin Seok Heo, Sung Kim, Do Hoon Lim, Kyoung-Mee Kim, Won Ki Kang
Clinical Cancer Research.2008; 14(1): 82. CrossRef
Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma
Jeeyun Lee, Kee‐Taek Jang, Chang‐Seok Ki, Taekyu Lim, Young Suk Park, Ho Yeong Lim, Dong‐Wook Choi, Won Ki Kang, Keunchil Park, Joon Oh Park
Cancer.2007; 109(8): 1561. CrossRef
Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis
Won-Suk Lee, Min Jung Kim, Seong Hyeon Yun, Ho-Kyung Chun, Woo Yong Lee, Sung-Joo Kim, Seong-Ho Choi, Jin-Seok Heo, Jae Won Joh, Yong Il Kim
Langenbeck's Archives of Surgery.2007; 393(1): 13. CrossRef
Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first‐line therapy in advanced nonsmall cell lung cancer
Se Hoon Park, Soo Jin Choi, Sun Young Kyung, Chang Hyeok An, Sang Pyo Lee, Jeong Woong Park, Sung Hwan Jeong, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Cancer.2007; 109(4): 732. CrossRef
A Phase II Study of Paclitaxel and Cisplatin as Salvage Therapy for Patients with Advanced or Metastatic Gastric Cancer
Bong-Gun Seo, Sung Yong Oh, Dong Mee Lee, Hyun Seung Yoo, Suee Lee, Seong-Geun Kim, Sung-Hyun Kim, Hyuk-Chan Kwon, Hyo-Jin Kim
Cancer Research and Treatment.2007; 39(1): 6. CrossRef
Salvage Chemotherapy with Docetaxel and Epirubicin for Advanced/Metastatic Gastric Cancer
Jae Yun Lim, Jae Yong Cho, Yong Han Paik, Dong Ki Lee, Sang In Lee, Hyo Jin Park, Se Joon Lee, Kwan Sik Lee, Dong Sup Yoon, Seung Ho Choi
Oncology.2007; 73(1-2): 2. CrossRef
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma
J. Lee, W.K. Kang, J.M. Kwon, S.Y. Oh, H.R. Lee, H.J. Kim, B.B. Park, H.Y. Lim, M.J. Han, J.O. Park, Y.S. Park
Annals of Oncology.2007; 18(1): 88. CrossRef
Malignancies in Korean Patients with Inflammatory Myopathy
Sang-Won Lee, Sang Youn Jung, Min-Chan Park, Yong-Beom Park, Soo-Kon Lee
Yonsei Medical Journal.2006; 47(4): 519. CrossRef
Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma
Se Hoon Park, Yeon Ho Park, Jeong Nam Lee, Soo‐Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Cancer.2006; 106(2): 361. CrossRef
The Synergism between Belotecan and Cisplatin in G astric Cancer
Joo Young Jung, Sang Hyun Song, Tae-Young Kim, Jung Hyun Park, Hyun-Soon Jong, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Noe Kyoung Kim
Cancer Research and Treatment.2006; 38(3): 159. CrossRef
Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil
Se Hoon Park, Woon Kee Lee, Min Chung, Yuna Lee, Sang Hoon Han, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Anti-Cancer Drugs.2006; 17(2): 225. CrossRef
Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study
Sang Hoon Han, Se Hoon Park, Jung Ho Kim, Jong Jun Lee, So Young Kwon, Oh Sang Kwon, Sun Suk Kim, Ju Hyun Kim, Keon Kug Kim, Yeon Ho Park, Jeong Nam Lee, Eunmi Nam, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
The Korean Journal of Internal Medicine.2006; 21(4): 225. CrossRef
Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer
Se Hoon Park, Jeeyun Lee, Se Hoon Lee, Joon Oh Park, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young Suk Park, Won Ki Kang, Keunchil Park, Seonwoo Kim, Soo Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Cancer Chemotherapy and Pharmacology.2006; 57(1): 91. CrossRef
A Pilot Study of Cisplatin, Irinotecan, Leucovorin and 5-fluorouracil (PILF) Combination Chemotherapy for Advanced Gastric Cancer
Se Hoon Park, Soo Yeon Jeon, Kwang Il Ko, Eunmi Nam, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon Ki Lee, Min Chung
Cancer Research and Treatment.2006; 38(3): 121. CrossRef
Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy
Se Hoon Park, Woon Ki Lee, Min Chung, Soo-Mee Bang, Eun Kyung Cho, Jae Hoon Lee, Dong Bok Shin
Cancer Chemotherapy and Pharmacology.2006; 57(3): 289. CrossRef
Progression of Atrophic Gastritis and Intestinal Metaplasia Drives Helicobacter pylori Out of the Gastric Mucosa
Hae Yeon Kang, Nayoung Kim, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook Hyang Jeong, Dong Ho Lee, Hyun Chae Jung, In Sung Song
Digestive Diseases and Sciences.2006; 51(12): 2310. CrossRef
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
Se Hoon Park, Yuna Lee, Sang Hoon Han, So Young Kwon, Oh Sang Kwon, Sun Suk Kim, Ju Hyun Kim, Yeon Ho Park, Jeong Nam Lee, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
BMC Cancer.2006;[Epub] CrossRef
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer
Keon Woo Park, Jin Seok Ahn, Young Suk Park, Jeeyun Lee, Jung Hoon Kang, Joon Oh Park, Ho Yeong Lim, Young-Hyuck Im, Won Ki Kang, Keunchil Park, Soon Il Lee
Cancer Chemotherapy and Pharmacology.2006; 59(1): 17. CrossRef
Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil and Low Dose Leucovorin in Patients with Advanced Colorectal Cancer
Yoon Mi Shin, Hae Suk Han, Seong Woo Lim, Byung Chul Kim, Kyung Suck Cheoi, Young Ook Eum, Seung Taek Kim, Ki Hyeong Lee
Cancer Research and Treatment.2005; 37(5): 284. CrossRef
Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy
H J Kang, H M Chang, T W Kim, M-H Ryu, H J Sohn, J H Yook, S T Oh, B S Kim, J-S Lee, Y-K Kang
British Journal of Cancer.2005; 92(2): 246. CrossRef
A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer
Eun Kyung Cho, Woon Ki Lee, Seok-Ah Im, Soon Nam Lee, Se Hoon Park, Soo-Mee Bang, Dong Kyun Park, Yeon Ho Park, Dong Bok Shin, Jae Hoon Lee
Oncology.2005; 68(4-6): 333. CrossRef
Interleukin‐1B (IL‐1B) polymorphisms and gastric mucosal levels of IL‐1β cytokine in Korean patients with gastric cancer
Young‐Woon Chang, Jae‐Young Jang, Nam‐Hoon Kim, Jae Won Lee, Hyo Jung Lee, Woon Won Jung, Seok‐Ho Dong, Hyo‐Jong Kim, Byung‐Ho Kim, Joung‐Il Lee, Rin Chang
International Journal of Cancer.2005; 114(3): 465. CrossRef
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
S C Oh, K H Park, I K Choi, S Y Yoon, S J Kim, J H Seo, C W Choi, B S Kim, S W Shin, J S Kim, Y H Kim
British Journal of Cancer.2005; 92(5): 827. CrossRef
Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer
Se Hoon Park, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon KI Lee, Min Chung
BMC Cancer.2005;[Epub] CrossRef
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach
Sung Kim, Do Hoon Lim, Jeeyun Lee, Won Ki Kang, John S. MacDonald, Chan Hyung Park, Se Hoon Park, Se-Hoon Lee, Kihyun Kim, Joon Oh Park, Won Seog Kim, Chul Won Jung, Young Suk Park, Young-Hyuck Im, Tae Sung Sohn, Jae Hyung Noh, Jin Seok Heo, Yong Il Kim,
International Journal of Radiation Oncology*Biology*Physics.2005; 63(5): 1279. CrossRef
Oxaliplatin, Folinic Acid and 5-Fluorouracil (FOLFOX-4) Combination Chemotherapy as Second-line Treatment in Advanced Colorectal Cancer Patients with Irinotecan Failure: A Korean Single-center Experience
Se Hoon Park, Ju Young Sung, Sang-Hoon Han, Jeong Heum Baek, Jae Hwan Oh, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Japanese Journal of Clinical Oncology.2005; 35(9): 531. CrossRef
CASPASE-8 Gene Is Inactivated by Somatic Mutations in Gastric Carcinomas
Young Hwa Soung, Jong Woo Lee, Su Young Kim, Jin Jang, Yong Gyu Park, Won Sang Park, Suk Woo Nam, Jung Young Lee, Nam Jin Yoo, Sug Hyung Lee
Cancer Research.2005; 65(3): 815. CrossRef
Impact of the New AJCC Staging System and Adjuvant Treatment in Rectal Cancer
Shin Ae Lee, Hyuk-Chan Kwon, Min Ah Park, Chang Kil Jung, Sung-Hyun Kim, Ki-Jae Park, Hong-Jo Choi, Hyung-Sik Lee, Mee Sook Roh, Jae-Seok Kim, Hyo-Jin Kim
Cancer Research and Treatment.2004; 36(2): 121. CrossRef
Combination Chemotherapy of Heptaplatin, Paclitaxel and 5-Fluorouracil in Patients with Advanced Gastric Cancer: a Pilot Study
Myung-Ju Ahn, Ho-Suck Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Oh Young Lee, Ho-Soon Choi, Sung-Joon Kwon
Cancer Research and Treatment.2004; 36(3): 182. CrossRef
Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
S-H Lee, W K Kang, J Park, H Y Kim, J H Kim, S I Lee, J O Park, K Kim, C W Jung, Y S Park, Y-H Im, M H Lee, K Park
British Journal of Cancer.2004; 91(1): 18. CrossRef
Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma
Jeeyun Lee, Joon Oh Park, Won Seog Kim, Se Hoon Park, Keon Woo Park, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Jaewon Joh, Kihyun Kim, Chul Won Jung, Young Suk Park, Young-Hyuck Im, Won Ki Kang, Mark H. Lee, Keunchi
Cancer Chemotherapy and Pharmacology.2004; 54(5): 385. CrossRef
Gefitinib (ZD1839) Monotherapy as a Salvage Regimen for Previously Treated Advanced Non-Small Cell Lung Cancer
Jinny Park, Byung Bae Park, Jee Youn Kim, Se-Hoon Lee, Soon Il Lee, Ho Young Kim, Jung Han Kim, Se Hoon Park, Kyung-Eun Lee, Joon Oh Park, Kihyun Kim, Chul Won Jung, Young Suk Park, Young-Hyuck Im, Won Ki Kang, Mark H. Lee, Keunchil Park
Clinical Cancer Research.2004; 10(13): 4383. CrossRef
A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers
Jinny Park, Yong Chan Ahn, Hojoong Kim, Se-Hoon Lee, Se Hoon Park, Kyung-Eun Lee, Do Hoon Lim, JoonOh Park, Kihyun Kim, Chul Won Jung, Young-Hyuck Im, Won Ki Kang, Mark H. Lee, Keunchil Park
Lung Cancer.2003; 42(2): 227. CrossRef
Delta 13C‐urea breath test value is a useful indicator for Helicobacter pylori eradication in patients with functional dyspepsia
YOUNG‐WOON CHANG, SUN‐KEE MIN, KYUNG‐JIN KIM, YO‐SEOB HAN, JOO‐HEE LEE, SEOK‐HO DONG, HYO‐JONG KIM, BYUNG‐HO KIM, JOUNG‐IL LEE, RIN CHANG
Journal of Gastroenterology and Hepatology.2003; 18(6): 726. CrossRef
Postoperative chemoradiotherapy for gastric cancer
S.H. Park, D.Y. Kim, J.S. Heo, D.H. Lim, C.K. Park, K.W. Lee, S.H. Choi, T.S. Sohn, S. Kim, J.H. Noh, Y.I. Kim, J.O. Park, K. Kim, W.S. Kim, C.W. Jung, Y.H. Im, M.H. Lee, K. Park, C.H. Park, W.K. Kang
Annals of Oncology.2003; 14(9): 1373. CrossRef
Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients
Young‐Woon Chang, Yo‐Seob Han, Dong‐Keun Lee, Hyo‐Jong Kim, Hyun‐Seok Lim, Jeong‐Seop Moon, Seok‐Ho Dong, Byung‐Ho Kim, Joung‐Il Lee, Rin Chang
International Journal of Cancer.2002; 101(5): 469. CrossRef

6,221 View
38 Download
69 Crossref

First
Prev
Page of 1
Next
Last

Search